Anika Therapeutics (ANIK) Accumulated Expenses (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Accumulated Expenses of $15.9 million for Q2 2026, up 40.68% year-over-year from $11.3 million in Q2 2025, and up 8.78% quarter-over-quarter from $14.6 million in Q1 2026.
Anika Therapeutics (ANIK) Accumulated Expenses (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Accumulated Expenses for 17 consecutive years, with $15.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accumulated Expenses rose 40.68% year-over-year to $15.9 million; the TTM figure through Jun 2026 stood at $15.9 million (up 40.68% YoY), while the FY2025 annual figure was $15.9 million, up 16.95% from the prior year.
- Accumulated Expenses climbed to $15.9 million in Q2 2026 per ANIK's latest filing, from $14.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $19.8 million in Q3 2023 and bottomed at $11.3 million in Q2 2025.
- Historically, Accumulated Expenses has averaged $16.1 million across 5 years, with a median of $15.9 million in 2025.
- Annual changes were most pronounced in 2025 — Accumulated Expenses slumped 31.53% — and 2026, when it soared 40.68%.
- Anika Therapeutics' Accumulated Expenses stood at $18.8 million in 2022, then decreased by 25.34% to $14.1 million in 2023, then fell by 3.55% to $13.6 million in 2024, then climbed by 16.95% to $15.9 million in 2025, then gained by 0.28% to $15.9 million in 2026.
- Business Quant data shows ANIK's Accumulated Expenses at $15.9 million in Q2 2026, $14.6 million in Q1 2026, and $15.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Anika Therapeutics | 286.14 Mn | 247.73 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.91 Mn |
| Mar 31, 2026 | 14.63 Mn |
| Dec 31, 2025 | 15.87 Mn |
| Sep 30, 2025 | 14.36 Mn |
| Jun 30, 2025 | 11.31 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Dec 31, 2024 | 13.57 Mn |
| Sep 30, 2024 | 18.69 Mn |
| Jun 30, 2024 | 16.13 Mn |
| Mar 31, 2024 | 18.44 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 19.81 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Mar 31, 2023 | 19.75 Mn |
| Dec 31, 2022 | 18.84 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Jun 30, 2022 | 16.95 Mn |
| Mar 31, 2022 | 15.23 Mn |
| Dec 31, 2021 | 17.85 Mn |
| Sep 30, 2021 | 17.34 Mn |